DawMed Systems PLC
23 August 2007
For Immediate Release 23 August 2007
DAWMED SYSTEMS PLC
('DawMed' or the 'Company')
DISTRIBUTORSHIP AGREEMENT FOR SALES AND SERVICE OF NEW BENCH TOP
WASHER-DISINFECTOR-DRYER
The Board of DawMed, the AIM listed medical device company which designs,
manufactures, sells and services healthcare decontamination equipment used by
NHS Trust hospitals, private hospitals, clinics and Primary Care practitioners,
is pleased to announce the signing of an Exclusive Distributorship Agreement
('Agreement') between its operating subsidiary company, DawMed International
Limited ('DMI') and Prestige Medical Ltd for Sales and Service of the new
'Prestige Medical WDD' bench top washer-disinfector-dryer to be manufactured by
DMI.
Prestige Medical Ltd is a wholly owned subsidiary company of BI Group PLC and is
an established major supplier of bench top sterilisers to the dentistry,
podiatry, veterinary, cosmetic and laboratory markets, with a current installed
base of more than 100,000 units, annual sales of over 8,000 units and fast
growing export achievements. For Prestige Medical Ltd, this Agreement enables it
to offer its customers a more complete decontamination system utilising its new
bench top washer-disinfector-dryer together with its well established bench top
sterilisers.
The Agreement provides for the sale by DMI of a substantial minimum annual
number of the new 'Prestige Medical WDD' bench top washer-disinfector-dryers to
Prestige Medical Ltd who will sell the machines into the private dentistry,
podiatry and laboratory markets in the UK, Europe, North America and ROW
regions. This Agreement, which is of considerable importance, size and worth to
DawMed, also represents the Company's second notable export achievement for this
type of medical device.
Commenting, Executive Chairman, Kevin Gilmore, said: 'Today's news is an
important positive for DawMed following this year's negatives, and represents
the second of two such agreements for a Distributor's new bench top
washer-disinfector-dryer to date. Other products in the Company's range are
currently the subject of Board discussions with a number of parties regarding
potentially positive and notable outcomes, which it hopes to announce to
shareholders in due course.'
Enquiries:
Kevin M Gilmore Tel: 01789 740010
Executive Chairman Mob: 07785 396666
Beaumont Cornish Limited
Roland Cornish Tel: 020 7628 3396
Bishopsgate Communications Limited
Dominic Barretto Tel: 020 7562 3350
For further information please visit Dawmed's web site at www.dawmed.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.